Tenofovir disoproxil for the treatment of chronic hepatitis B
National Institute for Health and Clinical Excellence
Record ID 32011000093
English
Authors' recommendations:
This guidance does not apply to people with chronic hepatitis B who also have hepatitis C, hepatitis D or HIV.Tenofovir disoproxil, within its marketing authorisation, is recommended as an option for the treatment of people with chronic HBeAg-positive or HBeAg-negative hepatitis B in whom antiviral treatment is indicated.
Details
Project Status:
Completed
URL for project:
http://www.nice.org.uk/nicemedia/live/12184/44890/44890.pdf
Year Published:
2009
URL for published report:
http://www.nice.org.uk/TA173
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
England
MeSH Terms
- Adenine
- Antiviral Agents
- Reverse Transcriptase Inhibitors
Contact
Organisation Name:
National Institute for Health and Care Excellence
Contact Address:
Level 1A, City Tower, Piccadilly Plaza, Manchester, M1 4BT
Contact Name:
nice@nice.nhs.uk
Contact Email:
nice@nice.nhs.uk
Copyright:
National Institute for Health and Clinical Excellence (NICE)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.